| Typicality: | 0.368 |
| Saliency: | 0.277 |
| in both these trials | 2 | temporal |
| under a contract | 2 | other |
| vaccine → be manufactured by → sanofi pasteur | 7 |
| vaccine → be produced by → sanofi pasteur | 6 |
| vaccine → be made by → sanofi pasteur | 6 |
| vaccine → be developed by → sanofi pasteur | 4 |
| negative | neutral | positive |
| 0.132 | 0.784 | 0.084 |
| Raw frequency | 23 |
| Normalized frequency | 0.277 |
| Modifier score | 0.500 |
| Perplexity | 41.127 |